Pharmaceutical News

RSS

Socioeconomic disadvantages linked to drug-related mortality

For the first time, researchers have found that problem drug users with less successful educational and employment careers are more likely to die of an overdose. Moreover, there is no link between parents' professional status and the likelihood that their problem drug-using child will die from an overdose.

17 Oct 2014

ORNL's Urban Dynamics Institute supports polio vaccination efforts in developing countries

The new Urban Dynamics Institute at the Department of Energy's Oak Ridge National Laboratory is working with the Bill & Melinda Gates Foundation to aid polio vaccination efforts in developing countries.

17 Oct 2014

NIAID announces license agreement to develop dual-purpose candidate vaccines for rabies, Ebola

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced a new license agreement aimed at advancing dual-purpose candidate vaccines to protect against rabies and Ebola viruses.

17 Oct 2014

Myths, misconceptions about seasonal flu and flu vaccine

It's that time of year again. As days shorten, evenings become chilly and the trees start a showy display of color, it's time to roll up your sleeve and get your annual flu vaccine.

16 Oct 2014

Kalorama Information: Experimental vaccine distribution in the UK points to growing flu vaccine market

Kalorama Information believes an experimental vaccine distribution in the United Kingdom and other similar developments point to a growing flu vaccine market, as well as a growing market for the production of these vaccines.

16 Oct 2014

Foreign-born residents with low vaccination rates face greater risk of exposure to diseases

Foreign-born residents with low vaccination rates and their relatives in the U.S. are at greater risk of exposure to several vaccine-preventable diseases, e.g. influenza; pneumococcal diseases; tetanus, diphtheria and pertussis; hepatitis A; hepatitis B; shingles; and HPV, the human papilloma virus, which can lead to some types of cancer.

16 Oct 2014

Actavis seeks FDA approval to market generic version of Quillivant XR

Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis' ANDA product is a generic version of Pfizer and Tris Pharma's Quillivant XR®, which is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.

16 Oct 2014

Epidural and spinal anesthesia safe for relieving pain during childbirth

Women seeking pain relief during childbirth should be comforted to know that epidural and spinal anesthesia are extremely safe, suggests a study of more than 80,000 women that reviewed anesthesia complications during obstetrical care.

16 Oct 2014

Columbia University professor recommends vaccination for people travelling abroad

Planning to travel outside the U.S. this holiday season? Check with your primary care provider or travel clinic when you book your flight.

16 Oct 2014

Federal prescription-subsidy program improves drug adherence in breast cancer patients

A federal prescription-subsidy program for low-income women on Medicare significantly improved their adherence to hormone therapy to prevent the recurrence of breast cancer after surgery.

16 Oct 2014

Pharmaceutical firms share data to enhance transparency of clinical trials for new drugs

To enhance the transparency of clinical trials for new drugs, a number of pharmaceutical firms have begun sharing data with investigators outside their own companies.

16 Oct 2014

Boehringer Ingelheim's OFEV (nintedanib) capsules receive FDA approval for IPF treatment

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved OFEV (nintedanib) capsules for oral use for the treatment of idiopathic pulmonary fibrosis (IPF).

15 Oct 2014

Imaxio, DKFZ partner to evaluate potential of IMX313 with candidate vaccine targeting HPV

Imaxio, a biopharmaceutical company specialized in vaccines, today announces that it has signed an option for a license agreement with the world-renowned German Center for Cancer Research (DKFZ – Deutsches Krebsforschungszentrum), based in Heidelberg. The financial terms of the agreement were not disclosed.

15 Oct 2014

Scientists create light-activated drug to help control type 2 diabetes

Scientists have created a drug for type 2 diabetes that is switched on by blue light, which they hope will improve treatment of the disease.

15 Oct 2014

Discovery could prolong life of people living with glioblastoma

Researchers at the University of Calgary's Hotchkiss Brain Institute and Southern Alberta Cancer Research Institute have made a discovery that could prolong the life of people living with glioblastoma – the most aggressive type of brain cancer. Samuel Weiss, PhD, Professor and Director of the HBI, and Research Assistant Professor Artee Luchman, PhD, and colleagues, published their work today in Clinical Cancer Research, which is leading researchers to start a human phase I/II clinical trial as early as Spring 2015.

14 Oct 2014

I.V. lidocaine can protect mastectomy patients against chronic pain

More than two-thirds of women who have had mastectomies struggle with persistent pain, but it doesn't have to be that way.

14 Oct 2014

Eye Co receives patent for new class of eye disease drugs

Australian ocular technology company Eye Co Pty Ltd has achieved a key commercial milestone, with a patent granted protecting its new class of eye disease drugs throughout the high value European market.

14 Oct 2014

Eisai, Helsinn Group announce FDA approval of AKYNZEO for prevention of CINV

Helsinn Group and Eisai Inc. announced today that the Food and Drug Administration (FDA) approved AKYNZEO® for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy.

13 Oct 2014

Pharmaceutical industry withdraws from the antibiotic space

The Centers for Disease Control and Prevention has said that at least 2 million Americans are sickened by antibiotic resistant infections each year and survive.

13 Oct 2014

Study shows diphenhydramine suppresses cough reflex sensitivity with Dr. Cocoa formulation

Cough is among the most common complaints for which patients seek medical attention. Leading cough researcher Peter V. Dicpinigaitis, M.D., Professor of Clinical Medicine at New York's Albert Einstein College of Medicine, recently conducted a new cough challenge study among adults, whose results were first presented at the European Respiratory Society International Congress in September 2014.

13 Oct 2014

Pharmaceutical News

Socioeconomic disadvantages linked to drug-related mortality

ORNL's Urban Dynamics Institute supports polio vaccination efforts in developing countries

NIAID announces license agreement to develop dual-purpose candidate vaccines for rabies, Ebola

Myths, misconceptions about seasonal flu and flu vaccine

Kalorama Information: Experimental vaccine distribution in the UK points to growing flu vaccine market

Foreign-born residents with low vaccination rates face greater risk of exposure to diseases

Actavis seeks FDA approval to market generic version of Quillivant XR

Epidural and spinal anesthesia safe for relieving pain during childbirth

Columbia University professor recommends vaccination for people travelling abroad

Federal prescription-subsidy program improves drug adherence in breast cancer patients

Pharmaceutical firms share data to enhance transparency of clinical trials for new drugs

Boehringer Ingelheim's OFEV (nintedanib) capsules receive FDA approval for IPF treatment

Imaxio, DKFZ partner to evaluate potential of IMX313 with candidate vaccine targeting HPV

Scientists create light-activated drug to help control type 2 diabetes

Discovery could prolong life of people living with glioblastoma

I.V. lidocaine can protect mastectomy patients against chronic pain

Eye Co receives patent for new class of eye disease drugs

Eisai, Helsinn Group announce FDA approval of AKYNZEO for prevention of CINV

Pharmaceutical industry withdraws from the antibiotic space

Study shows diphenhydramine suppresses cough reflex sensitivity with Dr. Cocoa formulation

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News